Routine quarterly compliance certificate for share dematerialization filed by Registrar

Compliance View source PDF Explain this filing

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.6%Reaction day

₹9196.00

prior close

₹9349.50

announcement price

In-mkt

timing

Nifty 100market+1.0%+2.6% vs market

Pharmaceuticals peers, median of 170sector+0.9%+2.7% vs sector

On the reaction day the stock moved 2.6 pts more than Nifty 100 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

+0.3

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.6+1.0+2.6+0.9+2.7

Next day

+3.9+0.2+3.7+0.8+3.1

+1.8-1.6+3.4-1.4+3.2

+1.3-0.4+1.7-1.4+2.7

+2.5-0.9+3.4-1.8+4.3

+0.8+0.5+0.3-2.0+2.9

-1.8+1.4-3.2-2.5+0.7

15d

+4.2pendingpending-2.7+6.9

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Divi's Laboratories filed a routine quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026. Their registrar and share transfer agent KFin Technologies confirmed that all share dematerialization requests received during the quarter were processed, listed on BSE and NSE, mutilated, and updated in the register of members within the required 15 day timeframe. This is a standard procedural filing.

Likely market impact

Routine regulatory compliance filing with no material impact on the business, operations, or stock price.